Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cutaneous Melanoma, Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04331093
What this trial is testing

Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma

Who this might be right for
Acral Melanoma
Di Wu 40
Testing effectiveness (Phase 2)Study completedNCT00336986
What this trial is testing

Efficacy Study of IL-21 to Treat Metastatic Melanoma

Who this might be right for
CancerMalignant Melanoma
Novo Nordisk A/S 54
Testing effectiveness (Phase 2)Ended earlyNCT05234437
What this trial is testing

A Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c Melanoma

Who this might be right for
Melanoma
QBiotics Group Limited 1
Testing effectiveness (Phase 2)UnknownNCT00002817
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06594991
What this trial is testing

Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma

Who this might be right for
Advanced Melanoma
Memorial Sloan Kettering Cancer Center 88
Testing effectiveness (Phase 2)WithdrawnNCT05561491
What this trial is testing

ONCOS-102 in Combination With Other Novel Immune-therapies in Advanced Treatment-resistant Melanoma Patients

Who this might be right for
Melanoma
Targovax Oy
Testing effectiveness (Phase 2)Ended earlyNCT01605162
What this trial is testing

Phase 2 Study of the Poly(ADP-Ribose) Polymerase Inhibitor E7016 in Combination With Temozolomide in Subjects With Wild Type BRAF Stage IV or Unresectable Stage III Melanoma

Who this might be right for
Wild Type BRAF Stage IV MelanomaUnresectable Stage III Melanoma
Eisai Inc. 8
Testing effectiveness (Phase 2)Study completedNCT00866840
What this trial is testing

Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Melanoma (Skin)
Rutgers, The State University of New Jersey 13
Early research (Phase 1)Ended earlyNCT00002947
What this trial is testing

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more
Yale University 35
Testing effectiveness (Phase 2)Ended earlyNCT00550654
What this trial is testing

Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain

Who this might be right for
Kidney CancerMelanoma (Skin)Metastatic Cancer+3 more
National Institutes of Health Clinical Center (CC) 1
Testing effectiveness (Phase 2)Study completedNCT00071981
What this trial is testing

Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Eastern Cooperative Oncology Group 175
Large-scale testing (Phase 3)Ended earlyNCT02288897
What this trial is testing

PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma

Who this might be right for
Cutaneous Melanoma
Provectus Biopharmaceuticals, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT00255762
What this trial is testing

Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 47
Not applicableStudy completedNCT02133222
What this trial is testing

Circulating Cell-free DNA in Metastatic Melanoma Patient: Mutational Analyses in Consecutive Measurement Before and After Chemotherapy

Who this might be right for
Metastatic (Stage IV) Melanoma
Centre Hospitalier Universitaire de Nice 22
Testing effectiveness (Phase 2)Study completedNCT00027586
What this trial is testing

Imatinib Mesylate in Treating Patients With Metastatic Melanoma

Who this might be right for
MelanomaSkin Neoplasms
M.D. Anderson Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Large-scale testing (Phase 3)UnknownNCT00052156
What this trial is testing

Vaccine Therapy for Patients With Stage IV Melanoma

Who this might be right for
Malignant Melanoma
CancerVax Corporation 670
Testing effectiveness (Phase 2)Ended earlyNCT02009384
What this trial is testing

Ipilimumab Administered to Stage IIIC Stage IV Melanoma After Reg. T Cell Depletion With Denileukin Diftitox

Who this might be right for
Metastatic Melanoma
University of Louisville 2
Early research (Phase 1)Study completedNCT01496807
What this trial is testing

Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 31
Large-scale testing (Phase 3)Ended earlyNCT00522834
What this trial is testing

Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma

Who this might be right for
Melanoma
Synta Pharmaceuticals Corp. 630
Next Page